JP Morgan Upgrades H.B. Fuller (FUL)
JP Morgan Upgrades H.B. Fuller to Neutral, Announces $58 Price Target
H.B. Fuller Issues Statement Defending Acquisition Strategy; Highlights Margin Growth And Deleveraging; Evaluates Potential Deal Talks With Advanced Medical Solutions Group
'H.B. Fuller Said to Bid Over £600 Million for AMS in Health Push' - Bloomberg News
Director Of H.B. Fuller Makes $65K Buy
H.B. Fuller Raises Quarterly Dividend From $0.235 to $0.245/Share
Citigroup Maintains Buy on H.B. Fuller, Raises Price Target to $70
UBS Maintains Neutral on H.B. Fuller, Lowers Price Target to $63
H.B. Fuller Company (FUL) Q1 2026 Earnings Call Transcript
H.B. Fuller Company 2026 Q1 - Results - Earnings Call Presentation
I'm Less Positive On H.B. Fuller After This Quarter (Downgrade)
H.B. Fuller Co. (NYSE:FUL) Delivers Profitable Q1 Amid Volume Decline, Updates 2026 Outlook
H.B. Fuller Raises FY2026 Adj EPS Guidance from $4.35-$4.70 to $4.55-$4.90 vs $4.52 Est.
H.B. Fuller Q1 Adj. EPS $0.57 Beats $0.56 Estimate, Sales $770.844M Miss $781.510M Estimate.
H.B. Fuller Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
H. B. Fuller Says Effective April 1, 2026, Co Will Implement A Minimum 10% Price Increase Across All Product Lines Globally
Citigroup Maintains Buy on H.B. Fuller, Lowers Price Target to $67
Top 3 Materials Stocks Which Could Rescue Your Portfolio In March
Seaport Research Highlights Margin Progress at H.B. Fuller (FUL), Flags Growth Uncertainty
We Think H.B. Fuller's (NYSE:FUL) Healthy Earnings Might Be Conservative
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.